Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,070,008
+$416,630 QoQ
Shares Held
12,200
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.14%
of 13F equity value
Holder Rank
#1,637
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $26,299,020 across 9 Drug Manufacturers - General names. ABBV ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,354 | $7,621,178 | |
| 2 | JNJ |
Johnson & Johnson
|
18,218 | $4,626,825 | |
| 3 | AMGN |
Amgen Inc
|
9,210 | $3,335,125 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
12,200 | $3,070,008 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,480 | $2,760,180 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
20,620 | $2,605,130 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
21,150 | $1,218,663 | |
| 8 | PFE |
Pfizer Inc
|
27,500 | $662,200 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,070,008 | 12,200 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,653,378 | 12,200 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,838,632 | 16,800 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,426,792 | 14,800 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,747,176 | 14,800 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,100,896 | 14,800 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,340,760 | 18,800 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,120,184 | 15,800 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,709,824 | 44,950 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,409,920 | 35,200 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,175,111 | 46,300 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,858,058 | 39,300 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,294,889 | 39,300 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,263,241 | 39,300 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,028,053 | 37,300 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $7,119,840 | 53,050 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,172,348 | 40,300 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,775,233 | 60,300 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $9,315,520 | 68,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,600,430 | 89,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,024,960 | 89,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,902,130 | 91,500 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,206,037 | 95,250 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,554,637 | 86,250 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $10,284,355 | 104,750 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,380,912 | 83,750 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||